Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 8,484 Shares

Scholar Rock Holding Corporation (NASDAQ:SRRK) insider Mo Qatanani sold 8,484 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $47.07, for a total transaction of $399,341.88. Following the completion of the transaction, the insider owned 98,445 shares in the company, valued at $4,633,806.15. This represents a 7.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Mo Qatanani also recently made the following trade(s):

• On Tuesday, February 17th, Mo Qatanani sold 7,989 shares of Scholar Rock stock. The shares were sold at an average price of $46.53, for a total transaction of $371,728.17.
• On Thursday, January 22nd, Mo Qatanani sold 14,898 shares of Scholar Rock stock. The shares were sold at an average price of $46.71, for a total transaction of $695,885.58.
• On Friday, January 16th, Mo Qatanani sold 8,406 shares of Scholar Rock stock. The shares were sold at an average price of $44.48, for a total transaction of $373,898.88.
• On Wednesday, January 14th, Mo Qatanani sold 13,112 shares of Scholar Rock stock. The stock was sold at an average price of $45.20, for a total value of $592,662.40.
• On Thursday, December 4th, Mo Qatanani sold 136,462 shares of Scholar Rock stock. The shares were sold at an average price of $45.21, for a total value of $6,169,447.02.

Scholar Rock Trading Down 0.1%

Shares of SRRK traded down $0.05 during mid-day trading on Wednesday, hitting $46.97. 474,449 shares of the company’s stock traded hands, compared to its average volume of 974,988. The business’s 50-day moving average price is $45.25 and its 200-day moving average price is $38.63. Scholar Rock Holding Corporation has a 1 year low of $22.71 and a 1 year high of $49.82. The firm has a market capitalization of $4.79 billion, a P/E ratio of -14.91 and a beta of 0.67. The company has a quick ratio of 6.30, a current ratio of 6.30 and a debt-to-equity ratio of 0.41.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. HC Wainwright boosted their target price on shares of Scholar Rock from $44.00 to $58.00 and gave the company a “buy” rating in a report on Monday, January 26th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Scholar Rock in a report on Thursday, December 11th. Wolfe Research began coverage on Scholar Rock in a research report on Tuesday, November 18th. They issued an “outperform” rating and a $42.00 price target on the stock. UBS Group began coverage on Scholar Rock in a research report on Wednesday, January 7th. They set a “buy” rating and a $60.00 price objective for the company. Finally, Barclays lifted their price objective on Scholar Rock from $45.00 to $52.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Four analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Scholar Rock currently has an average rating of “Buy” and an average price target of $51.14.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Three Seasons Wealth LLC increased its holdings in Scholar Rock by 2.1% in the 4th quarter. Three Seasons Wealth LLC now owns 10,968 shares of the company’s stock worth $483,000 after buying an additional 222 shares in the last quarter. IFP Advisors Inc boosted its holdings in shares of Scholar Rock by 294.1% during the 4th quarter. IFP Advisors Inc now owns 603 shares of the company’s stock valued at $27,000 after acquiring an additional 450 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Scholar Rock by 7.9% in the third quarter. Principal Financial Group Inc. now owns 6,214 shares of the company’s stock worth $231,000 after acquiring an additional 456 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Scholar Rock by 151.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after purchasing an additional 525 shares during the last quarter. Finally, California State Teachers Retirement System lifted its position in Scholar Rock by 0.9% during the second quarter. California State Teachers Retirement System now owns 62,372 shares of the company’s stock valued at $2,209,000 after purchasing an additional 577 shares during the period. 91.08% of the stock is owned by institutional investors.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).